News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|November 17, 2023

Distinguishing Between Different MDS Subtypes

An expert perspective on the variety of MDS subtypes is provided.

Episodes in this series

EP. 1 Myelodysplastic Syndrome (MDS) Overview

EP. 1 Myelodysplastic Syndrome (MDS) Overview

EP. 2 Distinguishing Between Different MDS Subtypes

EP. 2 Distinguishing Between Different MDS Subtypes

EP. 3 MDS-Related Complications Impacting Patient Quality of Life

EP. 3 MDS-Related Complications Impacting Patient Quality of Life

EP. 4 Economic Implications of MDS Management

EP. 4 Economic Implications of MDS Management

EP. 5 Examining Treatment Algorithms for MDS

EP. 5 Examining Treatment Algorithms for MDS

EP. 6 Growth Factor and Stem Cell Transplant Candidacy in MDS

EP. 6 Growth Factor and Stem Cell Transplant Candidacy in MDS

EP. 7 Novel Agents Contributing to Evolving MDS Therapy Strategies

EP. 7 Novel Agents Contributing to Evolving MDS Therapy Strategies

EP. 8 Benefits of Oral Therapies In MDS Treatment Adherence

EP. 8 Benefits of Oral Therapies In MDS Treatment Adherence

EP. 9 Adapting MDS Treatment Approach

EP. 9 Adapting MDS Treatment Approach

EP. 10 Novel Therapy Impact on Patient Quality of Life

EP. 10 Novel Therapy Impact on Patient Quality of Life

Video 11 - "Multidisciplinary Care Driving Effective MDS Treatment"

EP. 11 Multidisciplinary Care Driving Effective MDS Treatment

Video 12 - "Payor Considerations In MDS Management"

EP. 12 Payor Considerations In MDS Management

Video 12 - "Payor Considerations In MDS Management"

EP. 13 Navigating Insurance-Related Challenges Associated With MDS Treatment

Video 12 - "Payor Considerations In MDS Management"

EP. 14 Key Considerations Surrounding MDS Treatment

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Dr Katherine Tobon

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

ByBrooke McCormick,Katherine Tobon, PharmD, BCOP

February 7th 2026

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

February 6th 2026

Acalabrutinib | Image Credit: © Сергей Шиманович-stocka.dobe.com.jpeg

Real-World Evidence Backs Acalabrutinib in CLL Care

ByMaggie L. Shaw

February 6th 2026

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

February 6th 2026

Dr Susan Vadaparampil

Linking Community Screening Programs to Cancer Centers Boosts Trial Diversity: Susan Vadaparampil, PhD, MPH

ByBrooke McCormick,Susan Vadaparampil, PhD, MPH

February 6th 2026

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”

Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial

Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP

Exploring Identity, Appearance Experiences Among Patients With Alopecia

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text